Document Detail


What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010.
MedLine Citation:
PMID:  21718345     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This review summarizes key clinical findings from 5 guidelines and 21 systematic reviews on psoriasis published or indexed in the period November 2009 to October 2010. The highlights include the British Association of Dermatologists guidelines on the use of biological interventions in psoriasis, and guidelines on the efficacy and use of acitretin. Biological therapies were reviewed for use in specific patient groups (such as those with hepatitis C) and from a health-economics perspective. Another systematic review focused on outcome measures used to assess the severity of psoriasis. Finally, comorbidities including cardiovascular risk were the topic of four systematic reviews.
Authors:
A C Foulkes; D J C Grindlay; C E M Griffiths; R B Warren
Related Documents :
15878445 - Interest of postmortem-collected specimens in the diagnosis of fulminant meningococcal ...
24039125 - Non-immune hydrops fetalis: a prospective study of 53 cases.
1146945 - Childhood blindness in lebanon.
22844445 - Reliability of the peer-review process for adverse event rating.
11399385 - A case of withdrawal from the ghb precursors gamma-butyrolactone and 1,4-butanediol.
12848115 - Erythema gyratum repens in a case of resolving psoriasis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2011-07-01
Journal Detail:
Title:  Clinical and experimental dermatology     Volume:  36     ISSN:  1365-2230     ISO Abbreviation:  Clin. Exp. Dermatol.     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-20     Completed Date:  2011-10-26     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  7606847     Medline TA:  Clin Exp Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  585-9; quiz 588-9     Citation Subset:  IM    
Copyright Information:
© The Author(s). CED © 2011 British Association of Dermatologists.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acitretin / therapeutic use
Anti-Inflammatory Agents / therapeutic use
Biological Therapy / methods*
Humans
Keratolytic Agents / therapeutic use
Practice Guidelines as Topic*
Psoriasis / diagnosis,  therapy*
Severity of Illness Index
Grant Support
ID/Acronym/Agency:
G1000417//Medical Research Council; //Medical Research Council
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Keratolytic Agents; LCH760E9T7/Acitretin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  What's new in atopic eczema? An analysis of systematic reviews published in 2009-2010.
Next Document:  Genetic analysis of the Alteromonas macleodii [NiFe]-hydrogenase.